Josie Smith Research Scientist, NPHS

Slides:



Advertisements
Similar presentations
Meeting need and improving coverage workshop. Meeting need: calculating and improving coverage.
Advertisements

HIV in Europe Stockholm, 3.November 2009 Communication on combating HIV/AIDS in the EU and the neighbourhood - strategy and second action plan ( )
Developing Substance Misuse Education in the Borders.
Hepatitis C Education, Training & Awareness-raising Network Phase II Actions NHS Greater Glasgow and Clyde Hepatitis C Managed Care Network Event 11 June.
Putting Research Evidence to Work Research Seminar 14 th January 2009.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
Drug Awareness for Primary Schools Richard Boxer Drug Education Consultant Health & Well-Being Team (CSF) Safeguarding: Drug Education Richard Boxer, Drug.
HIV and Hepatitis C in non- MSM Rural Communities: Issues and Interventions Shari Wells-Weiss, CASAC Director of Prevention Services Southern Tier AIDS.
Slide 5.1 Topic 5. Supporting programs aimed at reducing the spread of HIV among and from IDU Needle and Syringe Programs Opioid Substitution Treatment.
Patient Advice and Liaison Service NHS Devon, Plymouth and Torbay The work of PALS Patient transport Health and Wellbeing Boards.
Departmental Perspectives on Viral Hepatitis
2009 GMAC Strategic Assessment. Key facts and figures The GMAC Strategic Assessment makes the case for early intervention. In Greater Manchester: During.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
Divergent Patterns of Amphetamine Use in the City and Rural Areas in Northwest Poland Sobeyko J (1), Leszczyszyn-Pynka M (2), Parczewski M (2), Burris.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
Working with SEPs: How do we expand Hepatitis Services ? Narelle Ellendon, RN HCV Director Harm Reduction Coalition, NYC
RCGP training online: new training in short bites Danny Morris, Expert Lead RCGP Hepatitis B and C Part 1.
DEVELOPING PRISON HEALTH RESEARCH PRIORITIES. Introduction At the ‘Innovation in Prison Healthcare’ conference held in May 2005 participants were invited.
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Guidance for AONB Partnership Members Welsh Member Training January 26/
Safe Immunization Practices and Prevention of Hepatitis B and C Susan Mackay Behaviour Change Project Safe Injection Global Network.
Drug Use and Hepatitis C Are we mindful of the gaps? Dave Liddell, SDF.
Reaching out to drug users and communities “ ” WDP Preventing HIV Yasmin Batliwala.
Developing a standardised introductory course for HCA’s in General Practice - lessons learnt and future directions.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Welsh Neglect Project The findings from the Welsh Government commissioned Welsh Neglect Project November 2015.
Substance Misuse Treatment Framework – Needle Exchange Implications for planning and practice Carry Burton North Wales Needle Syringe Programme & Harm.
David Flynn Ballymun Job Centre. The BJC was established in 1986 as a community response to a chronic unemployment situation The BJC is a voluntary organisation.
Problematic and injecting drug use – findings from the Harm Reduction Database (HRD) Presenter: Josie Smith, Health Protection, PHW.
Safety in Medicines: Raising the profile with the Royal Pharmaceutical Society Liz Rawlins Communications Officer 9 May 2011.
NPS Intravenous Use in the UK: Current Situation and Experiences Catherine Crawford, UK Focal Point.
South Tyneside Drug Action Team ImprovementsAndReform.
Homelessness The added value of transnational cooperation for local authorities.
Cyfnewidfa Cydraddoldeb a Hawliau Dynol Digwyddiad Rhanbarthol Equality and Human Rights Exchange Regional Event 13 September 2016, Disability Sport Wales.
The PROTECT study; a feasibility trial of a psychosocial intervention to reduce blood borne virus (BBV) risk A three country collaboration led by the.
Module 4: Engaging KPs with HIV and SRH Services
Key Population Community taking the Lead.
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
6% of adults had used one or more illicit drugs in last 12 months.
Who are we? The Partnership, one of several set up throughout Wales, is an independent group of social care providers in Mid-Wales, including representatives.
Enhanced Pharmacy Provision in Edinburgh:
LEARNING REPORT 2016 Disasters and Emergencies Preparedness Programme
Incorporating transition considerations into the new Global Fund funding cycle Mauro Guarinieri Senior Technical Adviser, Community Responses and Drug.
Session II: Communication and Outreach
Kate Yorke, Project Manager – MECC
“CareerGuide for Schools”
Opportunities for Growth
Gender Equality Ex post evaluation of the ESF ( )
National Programme for limiting spread of HIV/AIDS in Latvia 2008–2012
The role and state of the sector
STIs among people who use drugs
ENDING THE EPIDEMICS: A FOCUS ON PEOPLE WHO INJECT DRUGS
Cardiff Youth Support Services
Blood borne viral hepatitis action in Wales
NHS Lothian DN CPD Resource Project
1. Reduce harms from the main preventable causes of poor health
Key Stakeholders are aware of the Coalitions activities
SAFE Initiative – A Community Led Response
Strategy
Brent Allan Senior Coordinator
Insights from Children about Abuse and Neglect
Information and outreach
Tackling the wider determinants of health: Health Improvement Domain
East Sussex Community Resilience Programme
Brent Mental Health User Group
Migration Health - Canada and the RCM
July 2011 Karen Oldham Department of Health
COMPREHENSIVE SEXUALITY EDUCATION (CSE) PROVISION
Presentation transcript:

Josie Smith Research Scientist, NPHS Advancing the Health Protection agenda: Needle Exchange in Wales – raising the profile and identifying new initiatives Josie Smith Research Scientist, NPHS

Aims Evidence Recent research within Wales Development of the All Wales Needle Exchange Forum Key aims Working groups Website Raising the profile in Wales and beyond…

Comprehensive review of international evidence Alex Wodak and Annie Cooney 2006 ‘ There is compelling evidence that increasing the availability and utilisation of sterile injecting equipment by IDUs reduces HIV infection substantially’ ‘There is no convincing evidence of any major, unintended negative consequences’ Using the Bradford Hill criteria

HIV prevention ‘NSE are cost effective’ ‘NSE have additional worth while benefits apart from reducing HIV infection….’ ‘….not enough on own to control HIV infection among IDUs’

HCV prevention Lack of control studies & not going to happen But – in countries with poor NSE – high HCV prevalence HCV is transmitted by injecting risk behaviour – there is evidence the NSE reduces injecting risk behaviour therefore NSE has to be a pillar in HCV prevention

Reducing sharing: challenges in the provision of NSE Structural: the environment that creates situations where sharing is the default option (homeless/public injecting, prison injecting, poor NSE availability) Marginalisation: low self esteem, poor knowledge, vulnerability all disempowering the individual The social role of sharing: Sharing between partners & close friends not perceived as high risk, unequal power within relationships The drugs used: Heroin withdrawal and crack or amphetamine binges can create situations where sharing becomes the easiest option or accidental option

Hepatitis C prevalence and incidence amongst IDUs South Wales, London and Glasgow

HCV incidence Highest amongst the homeless Correlated with reports of paraphernalia sharing Correlated with reports of high rates of NS sharing Infection early in injecting careers

HCV incidence study NSE use amongst the follow up sero-negative cohort Drug agency / mobile 65% Pharmacy 22% Other people 12%

How is NSE perceived by IDUs in Wales? Needs Assessment Majority 88% of IDUs used NSE in area regularly, positive experiences were reported Approximately one fifth relied on someone else to get NS (distance, travel time, opening times, confidentiality & privacy) Swabs, citric acid water not available in many areas Pharmacy exchange - perception that exchange was often not confidential and concerns around staff attitude

Barriers to NSE use Qualitative study (49 in depth interviews) Availability Generally good in larger towns/cities Sometimes stock shortages in pharmacy NSE especially weekends Type At times range of equipment limited Quality sometimes substandard Quantity Number needed may vary – distance from exchange / work / injecting practices / other responsibilities Consistency across NSE important

Barriers to NSE use Qualitative study Geographic access Access can be a problem in some areas, particularly smaller towns and rural areas relaying on a single outlet Opening times Perceived to be slightly restrictive Fear of public exposure Key theme – particularly if close to family home - reluctance to disclose identity Homeless IDUs Absence of secure storage space

Barriers to NSE use Qualitative study Attitudes of staff IDUs Perceptions of negative stereotyping and discriminatory treatment by pharmacy NSE staff indicated as a barrier to accessing services Awareness among recent IDUs A priority

Important to acknowledge: Strong network of needle exchange services in Wales Range of outlets - pharmacy, voluntary, statutory, mobile and outreach Many highly motivated, experienced and dedicated needle exchange staff So how can services best move forward to address the challenges and barriers identified? What is the role of Health Protection in facilitating change?

Development of the Forum KEY AIMS To raise profile: - Challenge uninformed views with evidence and ongoing discussion Challenge practice of ‘anyone who is available’ Ensure presence in policy making and strategy development at regional and national level To highlight the extent and importance of the role of needle exchange services in Wales: In the wider context of harm reduction In the reduction in transmission of chronic disease especially hepatitis C and HIV Frontline in engaging injecting drug users

Development of the Forum To ensure high quality, accredited training and education available and received by all relevant staff: Recognition of ‘relationship’, confidentiality etc, interaction not transaction Interagency training To address issues of supply: Centralised purchasing – economies of scale Maximise consistency of supply including injecting paraphernalia

Development of the Forum To ensure equity of service To establish a standardised data collection system and build an evidence base for planning and developing services

Progress to date Established a Forum planning group Representation from all regions: Statutory and voluntary sector drug services community pharmacy CSP CPA Public Health Service Users

Progress to date WEBSITE: www.wnef.org.uk Central to open discussion and communication What you will find: Location mapping Resource library What’s new Forum About us – minutes, terms of reference etc Working groups

Progress to date Working groups: Special interest Initiated and developed by forum members Task led Research Development of best practice guidance and monitoring/evaluation tools Opportunity to work with individuals within and beyond Wales

Future developments Secure funding e.g. for maintaining website, developing working groups etc Develop working groups programme Continue to raise profile and influence policy and guidance e.g. WAG substance misuse strategy and forthcoming NICE guidance Tie in developments of Forum with those of the blood borne viral hepatitis action plan for Wales